This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Vision Expo 2024 – Stand 4
Vitamin B3 in glaucoma
About our research
The Vitamin B3 in Glaucoma Study is an international clinical trial looking at whether taking vitamin B3 (nicotinamide) can help protect nerve cells in glaucoma and slow down vision loss over two years. It’s a global, collaborative effort that will help us determine whether nicotinamide should be incorporated into clinical care for people with glaucoma.
What you’ll see
Learn more about nicotinamide – what we know so far, how it may be protective in glaucoma and where our current study is going.
Talk to us about
- Healthy ageing and glaucoma
- How vitamin B3 works in the eye
- Joining the study if you have glaucoma (we’re currently recruiting!).